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Objective: Synovitis is associated with pain and other symptoms in patients with knee osteoarthritis (OA),
and in patients with meniscal tears even in the absence of radiographic OA. Patients undergoing
arthroscopic partial meniscectomy were followed for 2 years to determine whether synovitis predicts
post-operative symptoms.
Design: Thirty-three patients scheduled for arthroscopy were recruited for this pilot study. Symptoms
were assessed using a knee pain scale, the Lysholm score, and the short form-12 (SF-12) pre-operatively
and at 16 weeks, 1 year and 2 years post-operatively. Synovial inﬂammation and hyperplasia were graded
on surgical biopsies. Linear mixed effects models were tested to determine whether inﬂammation or
hyperplasia is associated with outcome scores over time.
Results: Lysholm scores and SF-12 physical component sub-scores were worse pre-operatively in pa-
tients with inﬂammation (Lysholm: 52.42 [95% conﬁdence interval (CI) 42.37, 62.47] vs 72.38 [66.03,
78.72], P < 0.001; SF-12: 36.81 [28.26, 45.37] vs 46.23 [40.14, 52.32], P < 0.05). Up to 2-years post-
operatively, patients with inﬂammation achieved mean scores similar to those without inﬂammation. As
a result, the mean improvement in Lysholm scores was 13.01 [1.48e24.53] points higher than patients
without inﬂammation, P ¼ 0.03. 33% (4/12) of patients with inﬂammation still had fair to poor Lysholm
scores 2 years after surgery compared to 7% (1/15, P¼0.14) without inﬂammation. No association be-
tween hyperplasia and symptoms was noted.
Conclusions: In this pilot study of patients undergoing partial meniscectomy, synovial inﬂammation was
associated with worse pre-operative symptoms, but not with poorer outcomes in the ﬁrst 2 years post-
arthroscopy. Larger cohorts and longer follow-up should be pursued to conﬁrm this relationship, and
determine if the initial response is sustained.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a disease in which multiple joint struc-
tures are compromised, including cartilage, meniscus, bone, andC. R. Scanzello, Rush Univer-
Harrison Street, Suite 510,
-(312)-563-2267.
u, crscanzello@gmail.com
s Research Society International. Psynovial membrane1. Structural alterations seen on plain radio-
graphs, speciﬁcally osteophytes and joint space narrowing, can be
identiﬁed in approximately 34% of the United States population
over age 65, but in only about half are structural changes accom-
panied by pain and dysfunction2. Importantly, pain and related
symptoms are associated with more rapid structural progression3.
Therefore understanding factors responsible for symptom devel-
opment are essential to identify patients at risk of greater
morbidity and disability, and to identify modiﬁable disease targets
for therapeutic intervention.ublished by Elsevier Ltd. All rights reserved.
Table I
Synovial histopathologic grading (for H&E stained sections)
1) Mononuclear inﬂammation:
Grade 0 ¼ none
Grade 1 ¼ mild (0e1 perivascular aggregates per ﬁeld)
Grade 2¼moderate (>1 perivascular aggregate per ﬁeld focal* interstitial
inﬁltration)
Grade 3 ¼ marked (both perivascular and widespread* interstitial
aggregates)
2) Vascularity:
Grade 0 ¼ normal
Grade 1 ¼ mildly increased
Grade 2 ¼ markedly increased
3) Fibrosis of sublining:
Grade 0 ¼ absent
Grade 1 ¼ focal
Grade 2 ¼ widespread
4) Detritus:
Grade 0 ¼ absent
Grade 1 ¼ small particulate
Grade 2 ¼ large particulate
5) Synovial hyperplasiay:
Grade 0 ¼ normal (up to 2 cell layers thick)
Grade 1 ¼ hyperplasia I (3e4 cells thick)
Grade 2 ¼ hyperplasia II (>4 cell thick)
* Focal ¼ present in <50% of the ﬁeld. Widespread ¼ present in >50% of the ﬁeld.
y Hyperplasia evaluated at high power (40). All other features evaluated at low
power (5e10).
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patient-reported symptoms such as pain with presence and
severity of synovitis in patients with OA4. Synovitis also is associ-
ated with objective measures of knee joint dysfunction including
walking and stair climbing times5. We have reported that the
relationship between synovitis and symptoms applies to patients at
risk for OA, but without radiographic signs of OA structural alter-
ations, based on the analysis of a cohort of patients with meniscal
tears undergoing meniscectomy6.
In young sports-participants, traumatic meniscal tears are
among the most common knee joint derangements and these tears
are associated with an increased risk of OA development7. But the
most common meniscal derangements are degenerative meniscal
tears8 which can occur in the setting of pre-existing OA and are also
associated with risk of disease progression7. Patients with meniscal
tears, with or without concomitant OA, often seek surgical inter-
vention due to a variety of symptoms (pain, locking, stiffness,
inability to participate in speciﬁc activities). In fact, there are close
to 1 million arthroscopic meniscal procedures performed in the US
annually9, although meniscal derangement itself has not consis-
tently been associated with pain10e12.
The present longitudinal pilot study was designed to test the
hypothesis that synovitis detected at the time of surgery predicts
poorer symptomatic outcomes after arthroscopic meniscectomy.
This study was conducted on patients with meniscal tears but with
normal pre-surgical knee radiographs. Patient-reported knee
symptomsweremeasured at three post-operative time points using
the Lysholm score13, short form-12 (SF-12) health surveys14, and a
knee pain scale. The pre-operative characteristics and relationship
with baseline Lysholm scores of these patients have beenpreviously
published6. Here, we report analysis of the relationship between
synovitis measured at the time of surgery, and knee symptoms
using three outcome measures up to 2 years post-operatively.
Methods
Patients
The study was approved by the Institutional Review Board (IRB)
of the New England Baptist Hospital (NEBH), and all patients gave
written, informed consent. Inclusion and exclusion criteria, as well
as demographics and baseline characteristics, have been described
in detail previously.6 Brieﬂy, thirty-three patients with a history of
knee injury and a magnetic resonance imaging (MRI)-conﬁrmed
meniscal tear scheduled for arthroscopic partial meniscectomy
were recruited between September 2005 and April 2009. Patients
with radiographic evidence of OA (osteophytes or joint space nar-
rowing) were excluded. There were twenty-one males and twelve
females, median age was 45 interquartile range, (IQR 40e53), and
median body mass index (BMI) was 26.9 (IQR 24.7e28.1). The
majority (twenty-ﬁve patients) had complex meniscal tears with
multiple cleavage planes consistent with degenerative type tears,
and only 20% had completely normal cartilage surfaces as indicated
by an Outerbridge score15 of zero in all three knee compartments.
Synovial tissue collection and evaluation of synovitis
Knee synovial biopsies were obtained during surgery from three
locations (suprapatellar pouch, medial and lateral gutters). Biopsies
were taken fromareas that appeared inﬂamedor thickened.Whenno
inﬂammation was apparent, standard locations were used: femoral
aspects of the gutters and the central supratrochlear region in the
pouch. Biopsies fromﬁve patientswere insufﬁcient for analysis, so 28
patients contributed biopsies. Histologic features of synovitis16 were
evaluated on formalin-ﬁxed, parafﬁn-embedded, hematoxylin andeosin (H&E) stained synovial membrane sections. Inﬂammation was
evaluated on a semi-quantitative scale6 presented inTable I, based on
perivascularmononuclear cell aggregates. In addition, synovial lining
hyperplasia, vascularity, ﬁbrosis, and the presence of detritic frag-
ments of bone and cartilagewere graded independently (Table I). The
grading system was adapted from multiple sources16e19with input
from an experienced musculoskeletal Pathologist (ED). Randomly
chosen subsets of synovial specimens were scored by two indepen-
dent readers (ED, CRS) for assessment of inter- and intra-reader
reliability. However, the ﬁnal reported scores reﬂect those of a sin-
gle reader (the experienced musculoskeletal Pathologist, ED).
Outcome scores
Symptoms were assessed using three instruments. First,
Lysholm questionnaires were utilized to assess knee-speciﬁc
symptoms. The Lysholm questionnaire is a clinician-developed in-
strument measuring symptoms including pain, swelling, limp,
locking, and instability, as well as functional disability (stair
climbing, squatting, use of supports). A summed score is reported
on a scale of 0e100, where 100 ¼ no symptoms/disability13. Sec-
ond, the SF-12 health survey was utilized to measure general
physical and emotional health. Physical (PCS) and mental (MCS)
component summary sub-scores were calculated and expressed as
norm-based standardized scores14, with 50 equal to the population
mean and 10 the population standard deviation. Finally, patients
were also asked to assess their knee pain on a scale from 0 to 10
(0 ¼ no pain). All three instruments were administered pre-
operatively and at 16 weeks, 1 year and 2 years post-operatively.
Thirty-one patients completed the 2-year follow-up.
Measurement of chemokine transcript levels
mRNA levels of four chemokines and one chemokine receptor
(Interleukin (IL)-8, CeC Chemokine Receptor 7 (CCR7), CeC Chemo-
kine Ligand 19 (CCL19), CCL21 and CCL5) were measured in twelve
C.R. Scanzello et al. / Osteoarthritis and Cartilage 21 (2013) 1392e13991394suprapatellar synovial biopsies by real-time polymerase chain reac-
tion (PCR)6. These transcripts were chosen for analysis as they had
been identiﬁed as differentially expressed in biopsieswith orwithout
synovial inﬂammatory inﬁltrates by microarray analysis6. Cycle
threshold (Ct) values were normalized to glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH), and expression levels calculated20
relative to the mean of specimens without inﬂammation.
Statistical analyses
Inter- and intra-reader reliability of histopathology scores were
reported as aweighted kappa statistic. Between-group differences in
patient characteristics were evaluated with ManneWhitney U tests
(for continuous variables) or Fisher’s Exact test (for categorical vari-
ables). We used repeated measures analysis of variance (ANOVA) to
comparemean outcomes and change in outcomes inpatientswith or
without synovial inﬂammation, or with or without hyperplasia at
each timepoint.We thenused a linearmixedeffectsmodel21 to study
whether synovial inﬂammation or hyperplasia was associated inde-
pendently with Lysholm scores over time, controlling for age
(centered at 45), BMI (centered at 27), gender and cartilage integrity
measured by the Outerbridge score. We adjusted for cartilage integ-
rity assessed intra-operatively, since the presence of pre-existing OA
change is a known risk factor for poor outcomes after partial
meniscectomy22,23 and the majority of these patients had pre-
radiographic cartilage disease despite normal radiographs. We
tested whether mean Lysholm scores differed in patients with or
without inﬂammation at each time point using contrast statements
for the model. Associations between synovial chemokine transcript
levels and outcome scores were tested using Spearman’s correlation.
Results
Synovial histopathologic changes at the three different biopsy sites
Histological features were assessed in synovial biopsies from the
suprapatellar region and the medial and lateral gutters (described            Hyperplasia
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Fig. 1. Distribution of synovial histology scores in the three biopsy sites. (A) Lining hyperp
sections as described in Methods. Twenty-eight patients provided synovial biopsies from
contralateral to the meniscal tear in each individual. 0e2 on the x-axes represents the histas ipsilateral or contralateral to the meniscal tear). Detritic cartilage
and bone fragments were not identiﬁed in any patient. The distri-
butions of other histopathologic features are depicted in Fig. 1.
Synovial lining hyperplasia was most common, observed in 64% of
suprapatellar, 58% of ipsilateral, and 52% of contralateral biopsies.
Increased vascularity was most often identiﬁed in the contralateral
gutter (in 52% of patients). Fibrosis was the least common feature
observed, occurring in 25% of suprapatellar biopsies, 21% of ipsi-
lateral and 20% of contralateral biopsies. As previously reported,
inﬂammation was identiﬁed in 43% of patients, most commonly in
the suprapatellar location6. Scores are presented in Fig. 1 in com-
parison to other features of synovitis.Reliability of the grading scales
The inﬂammation score was previously reported to have
acceptable inter- and intra-rater reliability (weighted kappas of
0.87 and 1.0 respectively)6. Reliability of scores for other synovitis
features was variable. Weighted kappas (inter- and intra-rater,
respectively) for hyperplasia were 0.31 and 0.65, for vascularity
0.30 and 0.50, and for ﬁbrosis 0.23 and 0.25. Reliability was most
acceptable for inﬂammation and hyperplasia, and there was some
correlation between these features (Spearman r ¼ 0.30, P ¼ 0.01).
Therefore, relationships between outcomes and these two variables
were evaluated.Characteristics of patients with or without synovial inﬂammation or
lining hyperplasia
Patient characteristics stratiﬁed by presence of synovial
inﬂammation and hyperplasia are presented in Table II. Patients
with synovial inﬂammation were signiﬁcantly older, and had a
shorter duration between injury and surgery than those without6.
Characteristics (age, gender, BMI, Outerbridge scores, proportions
of medial and lateral tears and side of injury) were similar in pa-
tients with and without hyperplasia.Vascularity
0 1 2
Fibrosis
0 1 2
Suprapatellar
Ipsilateral
Contralateral
lasia, (B) vascularity, (C) inﬂammation, and (D) ﬁbrosis were graded on H&E stained
all three sites. The medial and lateral gutter biopsies were described as ipsilateral or
ologic grade (Table I).
Table II
Pt characteristics
 Inﬂammation (n ¼ 16) þ Inﬂammation (n ¼ 12) Pz  Hyperplasia (n ¼ 10) þ Hyperplasia (n ¼ 18) Pz
Age* 42.5 (30.2e51.8) 54.0 (45.0e57.5) 0.01 41.5 (28.2e55.2) 47.0 (41.8e51.8) 0.39
Gendery (male, female) 10, 6 9, 3 0.69 7, 3 12, 6 1.00
BMI* 26.2 (21.9e28.9) 26.6 (25.4e27.8) 0.56 27.0 (21.0e30.3) 26.4 (25.0e27.2) 0.83
Outerbridge score* 1 (0e2) 2 (1e3) 0.06 1 (0e2) 2 (1e3) 0.25
Injury to surgery (weeks)* 16.5 (8.0e27.5) 7 (3.2e18.0) 0.04 8.5 (4.8e24.5) 15.0 (6.8e24.5) 0.58
Meniscal teary (medial, lateral) 13, 3 10, 2 1.00 9, 1 14, 4 1.00
Side of injuryy (left, right) 9, 7 6, 6 1.00 5, 5 10, 8 1.00
Values in bold represent P < 0.05.
* Medians and interquartile ranges are presented for age, BMI, and weeks between injury and surgery.
y Numbers of patients are reported for gender, meniscal tear, and side of injury.
z P-values represent results from ManneWhitney U test for continuous variables (age, BMI, Outerbridge score, and weeks between injury and surgery), and Fisher's Exact
test for categorical variables (gender, side of injury, meniscal tear).
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As expected, Lysholm scores at each post-operative time point
improved from baseline levels (mean SD improvement of 27 16
points at 2 years), and reductions in pain scale were observed (pre-
operative mean  SD 3.7  2.3, 2-year mean 0.55  0.95) in the
group as awhole. SF-12 PCS sub-scores improved post-operatively
(pre-operative mean 42.2  11.0, 2-year mean 57.0  2.8), but the
MCS sub-scores remained stable over time (55.6  9.2 pre-
operatively, 54.2  6.9 at 2 years).Pre- and post-operative outcome scores in patients with or without
synovial inﬂammation and hyperplasia
Outcome scores in individual patients at each time point are
depicted graphically in Fig. 2. In our previous cross-sectional
analysis, we reported that patients with synovial inﬂammation in
this cohort demonstrated lower Lysholm scores pre-operatively
than those without, but no signiﬁcant differences in pre-operative
raw SF-12 scores or the knee pain scale were observed6. For thePre-op 16 wks 1 yr 2 yr
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Fig. 2. Pre- and post-operative symptom scores in patients undergoing meniscectomy over
surveys were administered to patients pre-operatively (pre-op), as well as at 16 weeks (wk
except the SF-12 MCS sub-scores were observed after surgery. Patients with inﬂammatio
Lysholm scores, (B) pain scale, (C) SF-12 PCS sub-scores, (D) SF-12 MCS sub-scores.current analysis, standardized norm-based SF-12 PCS and MCS
scores were calculated. The norm-based SF-12 PCS scores were
lower in patients with synovial inﬂammation than in those without
inﬂammation pre-operatively [36.81 (28.26, 45.37) vs 46.23 (40.14,
52.32), P < 0.05, Table III and Fig. 2(C)], consistent with the knee-
speciﬁc Lysholm scale. But in longitudinal follow-up, mean
Lysholm and SF-12 PCS scores did not differ signiﬁcantly at any
time point after surgery (Table III, repeated measures ANOVA). No
signiﬁcant differences in mean SF-12 PCS or Lysholm scores were
observed pre- or post-operatively comparing patients with or
without hyperplasia (Table III).
SF-12MCS scores and pain scores did not differ signiﬁcantly at
any time point between patients with or without inﬂammation
[Fig. 2(B and D)] or hyperplasia (data not shown).Change in symptom scores over time
In unadjusted analysis, Lysholm scores in patients with inﬂam-
mation improved more between baseline and 16 weeks (Table IV).
Mean improvement inpatientswith inﬂammationwas 35.10 [20.23,Pre-op 16 wks 1 yr 2 yr
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s), 1 year (yr) and 2 years post-operatively as described. Improvements in all measures
n are indicated by red triangles, patients without are indicated by black circles. (A)
Table III
Mean (95% CI) Lysholm and SF-12 PCS scores over time in patients with and without inﬂammation or hyperplasia
 Inﬂammation (n ¼ 16 total) þ Inﬂammation (n ¼ 12 total) P*  Hyperplasia (n ¼ 10 total) þ Hyperplasia (n ¼ 18 total) P*
Lysholm Pre-op 72.438 (66.03e78.72) (n ¼ 16) 52.42 (42.37e62.47) (n ¼ 12) <0.001 69.6 (62.71e76.49) (n ¼ 10) 60.6 (51.07e70.15) (n ¼ 18) >0.05
16 Weeks 87.71 (78.64e96.79) (n ¼ 14) 86.30 (75.67e96.93) (n ¼ 10) >0.05 85 (65.45e104.5) (n ¼ 7) 88 (81.59e94.41) (n ¼ 17) >0.05
1 Year 91.33 (84.86e97.80) (n ¼ 12) 86.56 (78.47e94.65) (n ¼ 9) >0.05 88.2 (78.14e98.26) (n ¼ 5) 89.6 (83.67e95.58) (n ¼ 16) >0.05
2 Years 93.27 (88.65e97.89) (n ¼ 15) 87.75 (78.91e96.59) (n ¼ 12) >0.05 96.2 (92.24e100.4) (n ¼ 10) 87.6 (81.13e94.16) (n ¼ 17) >0.05
SF-12
(PCS)
Pre-op 46.23 (40.14e52.32) (n ¼ 13) 36.81 (28.26e45.37) (n ¼ 9) <0.05 48.00 (39.04e56.95) (n ¼ 7) 39.75 (33.48e46.02) (n ¼ 15) >0.05
16 Weeks 52.98 (47.57e58.39) (n ¼ 12) 49.56 (40.94e57.52) (n ¼ 7) >0.05 52.00 (40.09e63.90) (n ¼ 5) 51.45 (46.46e56.45) (n ¼ 14) >0.05
1 Year 57.40 (54.86e59.94) (n ¼ 10) 49.55 (41.09e58.02) (n ¼ 6) >0.05 57.31 (51.65e62.97) (n ¼ 4) 53.51 (48.86e58.16) (n ¼ 12) >0.05
2 Years 57.04 (54.68e59.40) (n ¼ 12) 56.94 (55.45e58.43) (n ¼ 9) >0.05 57.69 (55.22e60.17) (n ¼ 6) 56.72 (54.90e58.53) (n ¼ 15) >0.05
* Repeated-measures ANOVA. Due to missing data, P values were estimated (not exact) using unweighted means analysis. Values in bold represent P < 0.05.
C.R. Scanzello et al. / Osteoarthritis and Cartilage 21 (2013) 1392e1399139649.97] points compared with 16.43 [6.56e26.30] points in patients
without inﬂammation (P < 0.05, difference ¼ 18.67 [2.19, 35.15]
repeated measures ANOVA). In patients without inﬂammation,
mean scores continued to improve from baseline at 1 and 2 years,
but stabilized in those with inﬂammation after 16 weeks so that
differences between these two groups at 1 and 2 years were no
longer statistically signiﬁcant (Table IV). A similar pattern was
observed when comparing patients with and without hyperplasia
(greater improvement between baseline and 16 weeks in patients
with hyperplasia), although these differences were not statistically
signiﬁcant (Table IV).
Improvements in SF-12 PCS sub-scores indicated by positive
changes from baseline to each post-operative time point were
observed in patients with and without inﬂammation, and patients
with and without hyperplasia. Again, patients with inﬂammation
and hyperplasia appeared to improve to a slightly greater extent
(Table IV), but differences between groups in this unadjusted
analysis were not statistically signiﬁcant.
We next used a linear mixed effects model (Table V) with a
correlation structure accounting for baseline Lysholm scores to test
whether the relationship between synovial inﬂammation and
change in symptoms over time was independent of age, BMI,
gender, or cartilage Outerbridge score. For this adjusted analysis,
we focused on the knee-speciﬁc metric (Lysholm). This approach
conﬁrmed the independent association of inﬂammationwith lower
Lysholm scores at baseline (estimate ¼ 20.8 [31.66, 9.90],
P ¼ 0.001, Table V). Consistent with the unadjusted analysis,
contrast statements for the model demonstrated that patients with
pre-operative inﬂammation achieved mean Lysholm scores similar
to those without inﬂammation at all post-operative time points (2-
year difference in mean scores ¼ 7.78 [18.73, 3.17], P ¼ 0.17,
Table V). As a result, their 2-year post-operative improvement in
Lysholm scores were 13.01 [1.48, 24.53] points higher than patients
without inﬂammation (P ¼ 0.03, Table V). The same approach
revealed no independent association of hyperplasia with baseline
Lysholm scores (estimate ¼ 4.90  5.6, P ¼ 0.40), and no differ-
ences in mean score or change from baseline at any post-operative
time point comparing patients with and without hyperplasia (data
not shown).Table IV
Mean change (95%CI) from pre-operative Lysholm and SF-12 PCS scores at three post-o
 Inﬂammation (n ¼ 16 total) þ Inﬂammation (n ¼ 12 total)
Lysholm D 16 Weeks 16.43 (6.56e26.30) (n ¼ 14) 35.10 (20.23e49.97) (n ¼ 10)
D 1 Year 20.75 (11.43e30.07) (n ¼ 12) 35.44 (25.48e45.41) (n ¼ 9)
D 2 Years 20.93 (11.93e29.93) (n ¼ 15) 35.33 (26.27e44.39) (n ¼ 12)
SF-12
(PCS)
D 16 Weeks 7.44 (0.08e14.81) (n ¼ 12) 12.54 (3.45e21.64) (n ¼ 7)
D 1 Year 14.82 (9.36e20.28) (n ¼ 10) 11.99 (2.55 to 26.52) (n ¼ 6
D 2 Years 10.27 (3.76e16.78) (n ¼ 12) 20.12 (12.45e27.80) (n ¼ 9)
* Repeated-measures ANOVA. Due to missing data, P values were estimated (not exacWe next stratiﬁed 2-year Lysholm scores using previously
described thresholds24. Outcomes after surgery using this scale
have been interpreted as excellent between 95 and 100, good be-
tween 84 and 94, fair between 65 and 83, and poor below 65. All
patients with synovial inﬂammation had scores in the fair to poor
range at baseline compared to 75% of patients without inﬂamma-
tion (Table VI and Fig. 2). Two years post-surgery, four patients
(33%) with inﬂammation scored in the fair to poor range, compared
to only 1 (7%) of patients without inﬂammation (P ¼ 0.14, Fisher’s
Exact test).
CCL19 and CCR7 mRNA relative expression levels were also
associated with Lysholm scores
We previously reported that CCL19 and CCR7 mRNA expression
was associated with synovial inﬂammation, and higher levels
correlated with worse pre-operative Lysholm scores6. In follow-up,
synovial relative expression levels of CCL19 and CCR7 were asso-
ciated with greater post-operative improvements in Lysholm score,
similar to associations observed with histologic inﬂammation.
Signiﬁcant associations were observed between expression levels
and change in Lysholm scores pre- to post-operatively at the 16
week (CCL19: Spearman’s r ¼ 0.708, P ¼ 0.050, CCR7: r ¼ 0.704,
P ¼ 0.016) and 2-year time points (CCL19: r ¼ 0.850, P ¼ 0.004;
CCR7: r ¼ 0.790, P ¼ 0.002).
Discussion
This longitudinal pilot study was designed to test whether the
presence of synovitis predicted worse post-operative symptoms in
patients undergoing arthroscopic meniscectomy. We previously
reported that synovial inﬂammation (deﬁned by the presence of
perivascular mononuclear cell inﬁltrates) is associated with pre-
operative symptoms using the Lysholm scale, a commonly used
measure of patient-reported knee symptoms6. In the current
analysis, similar associations between inﬂammation and pre-
operative symptoms were observed using a more general mea-
sure of physical health, the standardized PCS sub-score of the
SF-12 survey, strengthening our initial ﬁndings. In unadjustedperative time points in patients with and without inﬂammation or hyperplasia
P*  Hyperplasia (n ¼ 10 total) þ Hyperplasia (n ¼ 18 total) P*
<0.05 18.71 (0.10e37.33) (n ¼ 7) 26.47 (15.72e37.22) (n ¼ 17) >0.05
>0.05 21.60 (14.02e29.18) (n ¼ 5) 28.75 (19.54e37.96) (n ¼ 16) >0.05
>0.05 26.60 (18.52e34.68) (n ¼ 10) 27.76 (17.68e37.95) (n ¼ 17) >0.05
>0.05 4.58 (11.34 to 20.50) (n ¼ 5) 11.02 (5.10e16.93) (n ¼ 14) >0.05
) >0.05 12.61 (1.31 to 26.54) (n ¼ 4) 14.14 (7.29e20.99) (n ¼ 12) >0.05
>0.05 8.31 (1.10 to 17.73) (n ¼ 6) 16.96 (10.81e23.12) (n ¼ 15) >0.05
t) using unweighted means analysis. Values in bold represent P < 0.05.
Table V
Mixed effects model: association of inﬂammation with Lysholm scores
Time point Estimate Std.
error
95% CI P value
Intercept* 0 (Pre-op) 64.85 4.89 55.26, 74.43 <0.0001
Synovial inﬂammationy 0 20.78 5.55 31.66, 9.90 0.001
Gender (male)y 0 8.52 4.15 0.39, 16.66 0.05
BMIy 0 0.579 0.36 1.28, 0.12 0.12
Outerbridge scorey 0 0.605 1.44 2.21, 3.42 0.68
Agey 0 0.228 0.20 0.16, 0.62 0.28
Change in Lysholm
(no inﬂ.)z
0e16 Weeks 16.44 3.97 8.66, 24.22 0.0001
0e1 Year 20.01 4.18 11.82, 28.20 <0.0001
0e2 Years 22.32 3.97 14.54, 30.10 <0.0001
Difference, change
in Lysholm (inﬂ.
vs no inﬂ.)x
0e16 Weeks þ18.44{ 6.08 6.53, 30.36 0.004
0e1 Year þ14.44 6.33 2.04, 26.85 0.03
0e2 Years þ13.01 5.88 1.48, 24.53 0.03
Difference, mean
Lysholm (inﬂ.
vs no inﬂ.)k
16 Weeks 2.34{ 5.73 13.57, 8.89 0.69
1 Year 6.34 5.97 18.04, 5.36 0.29
2 Years 7.78 5.59 18.73, 3.17 0.17
* Intercept of the model, which can be interpreted as the adjusted mean Lysholm
score in patients without inﬂammation pre-operatively (time 0).
y Variables included, and association with baseline (pre-operative) Lysholm
scores.
z Mean change in Lysholm scores in patients without inﬂammation, adjusted for
gender, BMI, Outerbridge score and age, over three time periods indicated.
x Difference in Lysholm change from baseline between patients with inﬂamma-
tion and those without over three time periods, adjusting for variables as above.
k Difference between adjusted mean Lysholm scores in patients with or without
inﬂammation, tested by contrast statements for the model.
{ þ Indicates higher, and  indicates lower, in patients with inﬂammation
compared to those without.
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inﬂammation demonstrated improvements in knee symptoms
measured by the Lysholm score, and achieved similar mean scores
post-operatively up to 2 years (Table III). As they had started with
lower scores, post-operative improvement in Lysholm scores was
greater at 16 weeks in patients with inﬂammation compared to the
patients without inﬂammation (Table IV). Adjustment for other
factors conﬁrmed similar mean scores and greater improvement in
patients with inﬂammation compared to those without up to 2
years post-operatively. These ﬁndings suggest that the presence of
inﬂammation did not preclude improvement in the ﬁrst 2 years
after surgical intervention.
Multiple studies of outcomes from meniscal arthroscopy have
documented the long-term risk of developing structural and
symptomatic OA, and estimates suggest up to 50% of patients have
radiographic knee OA 10e20 years after undergoing meniscec-
tomy25. Short-term (3 month) prospective analysis of symptomatic
outcomes has also been reported23. To our knowledge, this is the
ﬁrst longitudinal analysis to speciﬁcally study the relationship be-
tween synovial histology and symptomatic outcomes after menis-
cal arthroscopy. As most patients did well within the 2-years of
follow-up, it is likely that the timeframe of this pilot study is
inadequate to capture sufﬁcient numbers of patients with pro-
gressive symptoms. Our ﬁnding that a greater proportion of pa-
tients with inﬂammation (33% vs 7% without inﬂammation) hadTable VI
Pre-operative and 2-year post-operative Lysholm score in patients with and without inﬂ
Lysholm scores Pre-operative
 Inﬂammation (n ¼ 16) þ Inﬂammation (
Good/excellent (84) 4 (25)* 0 (0)*
Fair/poor (83) 12 (75) 12 (100)
* Numbers of patients (% of patients).
y One patient in this group did not complete 2-year follow-up.scores in the fair to poor range (<84) at the 2-year post-operative
time point suggests that outcomes may change in the longer
follow-up period. Although not statistically signiﬁcant in this small
study, future work on validation of these ﬁndings in larger pop-
ulations and longer time periods is necessary.
Most histopathologic synovitis scoring systems that have been
applied to OA and knee injury combine various features of synovitis
(i.e., lining hyperplasia, inﬂammatory cell inﬁltration, vascularity,
ﬁbrosis) into a single summated score16,17. Summated scores have
shown to be useful in distinguishing different forms of arthritis and
in monitoring disease progression26e28. We chose to evaluate sy-
novitis features independently for two main reasons; ﬁrst, some
synovial changes have been reported to vary according to the stage
of OA16 and have not yet been evaluated in patients presenting for
meniscal arthroscopy; and secondly, individual synovial changes
may not reﬂect the same cellular and molecular processes, or have
the same relationship with symptoms. This analysis revealed a
number of interesting, and previously unreported ﬁndings.
First, comparison of ﬁve features at three different anatomic
sites demonstrated that no feature of synovitis was preferentially
found on the side of the meniscal tear, suggesting that the synovial
reaction in these patients can be a joint-wide phenomenon (Fig. 1).
Fibrosis was the least common abnormality identiﬁed in the
meniscectomy patients. Detritic fragments of bone and cartilage,
often identiﬁed in advanced OA patients16 were not found in any
patient in this study. Our previously reported inﬂammation score
was the most reliable, likely due to easy recognition of perivascular
aggregates on H&E staining. The hyperplasia scale was the second
most reliable indicator, although both inter- and intra-rater reli-
ability were lower than the inﬂammation score. The lower reli-
ability of the hyperplasia, vascularity and ﬁbrosis scores may relate
to the limitations with which these features can be recognized on
H&E stained sections, and the more subjective nature of their
grading scales (i.e., mild, moderate or marked). And at least with
regards to ﬁbrosis, the low kappas may reﬂect high chance agree-
ment in the setting of the low prevalence of this particular feature.
In unadjusted analyses, inﬂammation but not hyperplasia was
associated with worse pre-operative SF-12 PCS scores, consistent
with previous ﬁndings using the Lysholm scale. This suggests that
only speciﬁc features of synovitis (i.e., the mononuclear cell in-
ﬁltrates) may be related to symptoms in these patients. Alterna-
tively, the lower reliability of the hyperplasia score may be partly
responsible for the lack of association with outcomes. However,
identifying the aspects of synovial histopathology that are most
easily and reliably measured will simplify and focus efforts to
develop predictive tools and markers.
We had previously demonstrated that synovial inﬂammation
was associated with increased mRNA expression of a set of che-
mokines involved in leukocyte recruitment, and levels of the che-
mokine/receptor pair CCL19 and CCR7 were associated with worse
symptoms at baseline6. Herewe demonstrate that expression levels
of CCL19 and CCR7 also correlated with greater symptomatic im-
provements after surgery, similar to the associations seen with
histologic inﬂammation (Table III). In this analysis, we utilized
GAPDH as a reference gene, which has been demonstrated byammation
2 Years post-operative
n ¼ 12)  Inﬂammation (n ¼ 15y) þ Inﬂammation (n ¼ 12)
14 (93)* 8 (67)*
1 (7) 4 (33)
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We did not have sufﬁcient quantities of RNA to analyze additional
reference genes, however we observed no signiﬁcant difference
between mean GAPDH Ct values comparing synovial biopsies from
patients with or without inﬂammation (data not shown). Numbers
of specimens available for chemokine analysis were also not sufﬁ-
cient to pursue adjusted analyses, but the similar observations
made using both cellular and molecular measures of inﬂammation
strengthen our results, and suggest these mediators may be sur-
rogate markers of synovial inﬂammation in these patients.
Limitations of this pilot study include the small numbers and
limited duration of follow-up. In addition, the Lysholm score eval-
uates both patient-reported symptoms and functional disability on
a single scale, and minimal clinically important differences are not
known. However, our ﬁndings are strengthened by the similar re-
lationships found using a second, more general instrument, the SF-
12 PCS summary. We did not ﬁnd evidence of a relationship
between inﬂammation and a simple pain scale in this study. This
may be due to the small numbers of patients in this study, but may
also reﬂect a more complex symptom set in this population of
patients that was captured by the other outcomemeasures utilized.
Finally, the lack of data on OA radiographic progression makes
extending our results to the risk of structural OA progression
impossible in this cohort. Of note, the majority (80%) of patients in
this cohort already had evidence of pre-radiographic disease based
on intra-operative inspection, and progressive joint symptoms
rather than structural changes prompt patients to seek care.
Further studies are needed to determine if there is a relationship
between inﬂammation, subclinical cartilage pathology, and devel-
opment of structural disease progression.
In summary, in patients undergoing partial meniscectomy,
inﬂammation was associated with worse pre-operative symptoms
measured by two outcome scores, the knee-speciﬁc Lysholm scale
and the more general SF-12 PCS sub-score. In the ﬁrst 2-years
following surgery, patients with synovial inﬂammation achieved
similar mean scores post-operatively compared to those without
inﬂammation. By 2 years post-surgery, 33% (four of 12) of patients
with synovial inﬂammation had Lysholm scores in the fair to poor
range, compared with 7% (one of 15) of those without inﬂamma-
tion. Results suggest good 2 year outcomes post-meniscectomy, but
cannot rule-out a relationship between synovial inﬂammation and
progressive knee symptoms and should be conﬁrmed with longer
follow-up and larger cohorts.
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